GE, Boston Children's to create deep-learning tool for pediatric brain scans

A comparison of scans showing normal and abnormal pediatric brain development--Courtesy of Boston Children's Hospital

GE Healthcare is teaming up with Boston Children’s Hospital to develop digital tools for the diagnosis and treatment of childhood diseases with an initial focus on diagnostic imaging for brain disease.

In this first project, GE will contribute its software and cloud computing prowess, while Boston Children’s radiologists will pitch in their clinical knowledge. The goal will be to create a decision-support tool to help radiologists interpret pediatric MRI scans of the brain, according to a statement. This has the potential to save money, time and stress associated with misdiagnosis and unnecessary testing.

Because the brain changes so quickly during early childhood, a disorder may be misinterpreted as normal brain maturation, while normal development may be mistaken for abnormal changes and lead to unnecessary testing, according to the statement. While some image databases exist against which to compare pediatric images, they tend to be restricted to the pediatric units of major academic institutions. The partners will build a platform with scans from children of varying ages to be used worldwide as a reference when interpreting pediatric brain images.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

"Pediatric brain scans of children under the age of four can be particularly tricky to read because the brain is rapidly developing during this period of childhood," said Dr. Sanjay Prabhu, a pediatric neuroradiologist at Boston Children’s, in the statement. "Since pediatric neuroradiologists are very scarce, we approached GE Healthcare to collaborate on the development of digital tools to help physicians of varying expertise read the scans."

While this initial project focuses on brain imaging, GE plans to flesh out its stable of deep learning tools, aiming for a “hundreds of apps” in the GE Health Cloud by 2020, said Charles Koontz, GE Healthcare’s chief digital officer, in the statement.

GE’s other cloud-based solutions include a handful of radiology-based apps launched a year ago, such as apps for collaborative care planning for radiologists and pathologists, image and report sharing and storing and analyzing a patient’s imaging data over time. Additionally, the company added a new software application to its Health Cloud in March: Imbio’s Lung Density Analysis. The app is an automated, biomarker-based quantitative lung imaging analysis tool to provide clinicians with more insights into lung CT data.

Suggested Articles

Merck KGaA spinout iOnctura has raised a €15 million series A round to support an early-phase solid tumor trial of a PI3Kδ inhibitor.

The clinical success comes months before the FDA is set to decide whether to approve the survival motor neuron-2 splicing modifier.

Bayer CEO Werner Baumann stressed “less and less trust in society" for technology advances as a hurdle for pharma companies working on gene editing.